A new era in diabetes care: key takeaways from ISPAD50
The 50th Anniversary of the ISPAD (International Society for Paediatric and Adolescent Diabetes) Conference, held in Lisbon from October 16-19 2024, was an extraordinary gathering of experts, researchers, healthcare professionals, and advocates, all united by a shared mission: to advance paediatric diabetes care globally.
Themed “Inclusion & Innovation in Paediatric Diabetes”, this year’s conference marked a significant milestone in ISPAD’s half-century of groundbreaking work, encapsulating decades of progress while laying the foundation for future advancements.
Our #dedoc° voices — diabetes advocates from all walks of life — attended ISPAD50 in Lisbon in October 2024. Source: Tinotenda Dzikiti
The ISPAD50 conference unfolded against the backdrop of some of the most pressing challenges in paediatric diabetes care. From exploring the latest developments in immune modulation and beta cell replacement to showcasing the potential of artificial intelligence in diabetes management, the sessions were rich with information and insights. However, the central focus remained on bridging disparities in access to care, a reminder of the ongoing inequities experienced worldwide, particularly in low-resource settings.
T1D screening and the integration of technology in diabetes care
A key topic that resonated across many sessions was the growing importance of genetic and antibody screening for type 1 diabetes (T1D). Professor Chantal Mathieu eloquently captured this sentiment, highlighting Europe’s strides in implementing general population screening programs. Italy’s role as a pioneer in this area was acknowledged, being the first to roll out such initiatives, a move that could fundamentally alter how T1D is diagnosed and managed in its early stages. Early screening offers hope for reducing diabetic ketoacidosis (DKA) and improving glycemic management, enabling better psychological preparation for families and children alike.
Time to develop diabetes management skills, psychologically adjust to a new diagnosis, and avoid DKA were amongst the potential benefits of early screening for type 1 diabetes. Source: Tinotenda Dzikiti
Another core theme was the integration of technology into diabetes care. The ISPAD guidelines emphasised the importance of offering real-time or intermittently scanned continuous glucose monitoring (CGM) systems at the earliest opportunity. The consensus among experts was that CGM can significantly enhance the quality of life for youth managing T1D, helping them navigate the complexities of insulin dosing and glucose control with greater ease. This message was supported by examples of advanced automated insulin delivery systems that were showcased at the event, signalling a new era in diabetes care that is shifting from mere hormone substitution to holistic disease modification.
A particularly engaging discussion was centred around the role of AI-based decision support systems (DSS) in diabetes management. While AI promises to improve outcomes, empower patients, and personalise care, it comes with challenges related to data privacy, regulation, and trust. These themes are critical as the global diabetes community continues to navigate an increasingly data-driven healthcare landscape.
The potential benfits and the challenges of introducing artificial intelligence (AI) to diabetes management were discussed at ISPAD 2024. Source: Tinotenda Dzikiti
Collaboration, education and inclusivity: bringing HCPs, advocates and PwD together
Throughout the conference, there was a strong emphasis on collaboration, education, and inclusivity. The presence of healthcare professionals, advocates, and people with diabetes under one roof fostered rich dialogue and knowledge-sharing. There were moving stories from families and children living with diabetes, as well as reminders of the importance of centring patient experiences in all facets of care. The sessions were designed to empower not only researchers and healthcare providers but also individuals with diabetes, stressing the importance of involving all stakeholders in discussions around care innovation and policy development.
The vibrant host city of Lisbon served as the perfect backdrop for the event. Portugal, known for its spirit of inclusion and rich history, provided an inspiring environment for participants to network, share ideas, and form meaningful connections. The conference concluded with renewed commitments to tackling global disparities in diabetes care and advancing innovative research to improve the lives of children and adolescents worldwide.
In conclusion, ISPAD50 was not just a celebration of past achievements but a springboard into the future of paediatric diabetes care. It underscored the urgency of global collaboration in tackling challenges like equitable access to insulin, improving technological integration, and ensuring that families receive the education and support they need.
This post was made possible through the generous support of #dedoc°, who funded my accommodation and flights to and from Lisbon.
Found this article insightful? Please spread the word and share it with your network.